ClinConnect ClinConnect Logo
Search / Trial NCT06316193

The Use of the Diary in Neonatal Pathology: a Mixed-method Study for Collecting and Analyzing the Experience of Parents and Health Care Personnel.

Launched by IRCCS OSPEDALE SAN RAFFAELE · Mar 11, 2024

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how parents of newborns in the Neonatal Pathology unit, like those born prematurely or with low birth weight, use diaries to express their experiences during their child’s hospital stay. The study aims to understand how this process affects their feelings, such as stress and depression, and how supported they feel during this challenging time. The diary is already part of the care routine, so parents will be asked to share their thoughts and feelings while also providing information about their experiences.

To participate, parents need to have a premature baby (born at 35 weeks or less) or a baby weighing 2 kg or less when born, and they must be able to understand and express themselves in Italian. Healthcare workers in the Neonatal Pathology unit can also join if they agree to participate. Participants can expect to share their experiences in a supportive environment, which may help improve care for families in similar situations. The study is currently recruiting participants, and all involved will be asked to sign a consent form to ensure they understand what participation involves.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • for the parents:
  • signed informed consent;
  • parents of premature infant with gestational age less than or equal to 35 gestational weeks and with birth weight less than or equal to 2kg.
  • for healthcare providers:
  • healthcare personnel from the O.U. of Neonatal Pathology;
  • signed informed consent.
  • Exclusion Criteria:
  • for parents:
  • non-understanding or inability to express themselves in Italian language;
  • parent of premature infant with gestational age greater than 35 gestational weeks and with birth weight greater than 2kg
  • unsigned informed consent.
  • for health workers:
  • healthcare personnel not working in the O.U. of Neonatal Pathology;
  • unsigned informed consen

About Irccs Ospedale San Raffaele

IRCCS Ospedale San Raffaele is a leading research hospital and clinical trial sponsor based in Milan, Italy, renowned for its commitment to advancing medical knowledge and improving patient care through innovative research. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with cutting-edge scientific research, focusing on a wide range of therapeutic areas including oncology, neurology, and cardiovascular diseases. The institution is dedicated to conducting high-quality clinical trials that adhere to rigorous ethical standards, fostering collaboration among multidisciplinary teams to translate scientific discoveries into effective treatments for patients. Through its robust infrastructure and expertise, IRCCS Ospedale San Raffaele plays a pivotal role in shaping the future of healthcare both nationally and internationally.

Locations

Milano, Mi, Italy

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported